Next-Generation Sequencing Concordance Analysis of Comprehensive Solid Tumor Profiling between a Centralized Specialty Laboratory and the Decentralized Personal Genome Diagnostics elio Tissue Complete Kitted Solution

This publication has 20 references indexed in Scilit:

• Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
  Annals of Oncology, 2018
• Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
  Science, 2018
• Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
  JAMA Oncology, 2018
• Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
  New England Journal of Medicine, 2018
• High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
  Cancer Discovery, 2017
• High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis
  Cancer Research, 2017
• Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
  Science, 2015
• Signatures of mutational processes in human cancer
  Nature, 2013
• Genome sequencing and cancer
  Current Opinion in Genetics & Development, 2012
• High-throughput oncogene mutation profiling in human cancer
  Nature Genetics, 2007